Update from San Francisco 2018

GU CONNECT has summarised the highlights of the recent ASCO GU 2018 meeting for you.

Non-metastatic castration-resistant prostate cancer (M0 CRPC) by Prof. Evan Y. Yu, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, USA

Urothelial carcinoma (UC) by Asst. Prof. Shilpa Gupta, Masonic Cancer Center, University of Minnesota, USA

Renal cell carcinoma (RCC) by Prof. David Pfister, University Hospital of Cologne, Germany